ASCO 2019 | CLEOPATRA: changes in breast cancer natural history

Sandra Swain

Sandra Swain, MD, FASCO, of the Georgetown University Medical Center, Washington, DC, outlines the end-of-study analysis of the CLEOPATRA (NCT00567190) breast cancer trial. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics